JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

Search

Quanterix Corp

Închisă

SectorSănătate

3.38 8.68

Rezumat

Modificarea prețului

24h

Curent

Minim

3.33

Maxim

3.38

Indicatori cheie

By Trading Economics

Venit

10M

-23M

Vânzări

3.7M

44M

Marjă de profit

-52.712

Angajați

450

EBITDA

15M

-17M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+61.76% upside

Dividende

By Dow Jones

Următoarele câștiguri

6 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-145M

151M

Deschiderea anterioară

-5.3

Închiderea anterioară

3.38

Sentimentul știrilor

By Acuity

50%

50%

155 / 347 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

3 mai 2026, 23:47 UTC

Câștiguri

National Australia Bank Warns of Economic Shock as 1st Half Profit Falls -- Update

3 mai 2026, 22:35 UTC

Câștiguri

National Australia Bank Holds Dividend Despite 19% 1st Half Profit Drop

3 mai 2026, 23:39 UTC

Market Talk

Gold Edge Higher Amid Signs of Resilience -- Market Talk

3 mai 2026, 23:34 UTC

Market Talk

Oil Declines Amid Mild Risk-on Sentiment -- Market Talk

3 mai 2026, 23:32 UTC

Câștiguri

National Australia Bank Warns of Economic Shock as 1H Profit Falls -- Update

3 mai 2026, 23:30 UTC

Market Talk

Nickel Industries Result Shows Power of Higher Prices -- Market Talk

3 mai 2026, 23:20 UTC

Market Talk

RBA Likely to Hike Rates; Guidance and Board Split Key -- Market Talk

3 mai 2026, 23:16 UTC

Achiziții, Fuziuni, Preluări

GameStop Is Offering to Buy eBay for $56 Billion, CEO Ryan Cohen Says -- WSJ

3 mai 2026, 22:57 UTC

Achiziții, Fuziuni, Preluări

GameStop Is Offering to Buy eBay For $56 Billion, CEO Ryan Cohen Says -- WSJ

3 mai 2026, 22:57 UTC

Achiziții, Fuziuni, Preluări

GameStop Has Roughly 5% Stake in eBay, Cohen Says -- WSJ

3 mai 2026, 22:57 UTC

Achiziții, Fuziuni, Preluări

GameStop Offering to Buy eBay for $125 a Share, or About $56 Billion, CEO Ryan Cohen Says -- WSJ

3 mai 2026, 22:57 UTC

Achiziții, Fuziuni, Preluări

GameStop Is Prepared to Run Proxy Fight If eBay Isn't Receptive to a Deal, Cohen Says -- WSJ

3 mai 2026, 22:57 UTC

Achiziții, Fuziuni, Preluări

GameStop Has Around $20 Billion in Debt Financing Committed From TD Bank, Cohen Says -- WSJ

3 mai 2026, 22:45 UTC

Market Talk

Global Equities Roundup: Market Talk

3 mai 2026, 22:45 UTC

Market Talk

Low-Cost Miners in Spotlight Amid High Energy Prices -- Market Talk

3 mai 2026, 22:20 UTC

Câștiguri

National Australia Bank Holds Dividend Despite 19% 1H Profit Drop

3 mai 2026, 22:08 UTC

Câștiguri

NAB's 1H Included Previously Announced A$1.35B Software Amortization Charge>NAB.AU

3 mai 2026, 22:05 UTC

Câștiguri

NAB 1H Net Interest Income A$9.16B Vs. A$8.445B>NAB.AU

3 mai 2026, 22:05 UTC

Câștiguri

NAB 1H Credit Impairment Charge A$706M Vs. A$348M>NAB.AU

3 mai 2026, 22:05 UTC

Câștiguri

NAB 1H Operating Expenses A$5.02B Vs. A$4.81B>NAB.AU

3 mai 2026, 22:04 UTC

Câștiguri

NAB 1H Net Interest Margin 1.81%>NAB.AU>NAB.AU

3 mai 2026, 22:03 UTC

Câștiguri

NAB 1H Cash Return on Equity Ex-Large Notable Items 11.6%>NAB.AU

3 mai 2026, 22:03 UTC

Câștiguri

NAB 1H Cash Return on Equity 8.5%>NAB.AU

3 mai 2026, 22:02 UTC

Câștiguri

NAB 1H CET1 Capital Ratio 11.65% Vs. 12.01%>NAB.AU

3 mai 2026, 22:02 UTC

Câștiguri

NAB 1H Cash Earnings A$2.64B>NAB.AU

3 mai 2026, 22:02 UTC

Câștiguri

NAB 1H Cash Earnings Ex-Notable Items A$3.59B Vs. A$3.58B>NAB.AU

3 mai 2026, 22:01 UTC

Câștiguri

National Australia Bank Keeps Dividend at A$0.85 >NAB.AU

3 mai 2026, 22:01 UTC

Câștiguri

National Australia Bank 1H Rev A$11.16B Vs. A$10.28B >NAB.AU

3 mai 2026, 22:01 UTC

Câștiguri

National Australia Bank 1H Net A$2.75B Vs. Net A$3.41B >NAB.AU

3 mai 2026, 15:06 UTC

Câștiguri

Berkshire's Greg Abel Marks His First Annual Meeting as CEO. We'd Give Him a B-Plus. -- Barrons.com

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

61.76% sus

Prognoză pe 12 luni

Medie 5.5 USD  61.76%

Maxim 7 USD

Minim 4 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

155 / 347 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat